SCOPUS 정보 검색 플랫폼

Volumn 126, Issue 3, 2004, Pages 942-943

Long-Term Oral Tacrolimus in Refractory to Infliximab Fistulizing Crohn's Disease: Comments from Spanish Experience [7] (multiple letters)

(2) González Lama, Yago a Sandborn, William J b

a Mayo Clinic ^*

b MAYO CLINIC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; PLACEBO; STEROID; TACROLIMUS;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOSE RESPONSE; DRUG BLOOD LEVEL; ENTERITIS; FISTULA; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 1542347653 PISSN: 00165085 EISSN: None Source Type: Journal
DOI: 10.1053/j.gastro.2004.01.046 Document Type: Letter

Times cited : (2)

References (7)

1
- 0041665068
- Tacrolimus for the treatment of fistulas in patients with Crohn’s disease: a randomized, placebo-controlled trial
- W.J. Sandborn D.H. Present K.L. Isaacs C.W. Douglas E. Greenberg S.B. Hanauer B.G. Feagan L. Mayer T. Jonson J. Galanko C. Martı́n R.S. Sandler Tacrolimus for the treatment of fistulas in patients with Crohn’s disease a randomized, placebo-controlled trial Gastroenterology 125 2003 380 388
- (2003) Gastroenterology , vol.125 , pp. 380-388
- Sandborn, W.J.¹ Present, D.H.² Isaacs, K.L.³ Douglas, C.W.⁴ Greenberg, E.⁵ Hanauer, S.B.⁶ Feagan, B.G.⁷ Mayer, L.⁸ Jonson, T.⁹ Galanko, J.¹⁰ Martı́n, C.¹¹ Sandler, R.S.¹²

2
- 85120210641
- Oral tacrolimus therapy: experience in refractory to anti-TNF fistulizing Crohn’s disease
- Y. González Lama S. Tabernero N. Fernández Puga F. Pons B. Velayos M. Vera L. Abreu Oral tacrolimus therapy experience in refractory to anti-TNF fistulizing Crohn’s disease Gut 51 Suppl. III 2002 A303
- (2002) Gut , vol.51 , Issue.Suppl. III , pp. A303
- González Lama, Y.¹ Tabernero, S.² Fernández Puga, N.³ Pons, F.⁴ Velayos, B.⁵ Vera, M.⁶ Abreu, L.⁷

3
- 0028873006
- Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index
- E.J. Irvine Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index J Clin Gastroenterol 20 1995 27 32
- (1995) J Clin Gastroenterol , vol.20 , pp. 27-32
- Irvine, E.J.¹

4
- 0033228560
- Combination therapy with oral tacrolimus (FK 506) and Azatioprine or 6-mercaptopurine for treatment refractory Crohn’s disease perianal fistulae
- P.W. Lowry A.L. Weaver W.J. Tremaine W.J. Sandborn Combination therapy with oral tacrolimus (FK 506) and Azatioprine or 6-mercaptopurine for treatment refractory Crohn’s disease perianal fistulae Inflamm Bowel Dis 5 1999 239 245
- (1999) Inflamm Bowel Dis , vol.5 , pp. 239-245
- Lowry, P.W.¹ Weaver, A.L.² Tremaine, W.J.³ Sandborn, W.J.⁴

5
- 0037282938
- Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease
- G. Van Assche D. Vanbeckevoort D. Bielen Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease Am J Gastroenterol 98 2003 332 339
- (2003) Am J Gastroenterol , vol.98 , pp. 332-339
- Van Assche, G.¹ Vanbeckevoort, D.² Bielen, D.³

6
- 0034123022
- Tacrolimus. A further update of its pharmacology and therapeutic use in the management of organ transplantation
- G.L. Plosker R.H. Foster Tacrolimus. A further update of its pharmacology and therapeutic use in the management of organ transplantation Drugs 59 2000 323 389
- (2000) Drugs , vol.59 , pp. 323-389
- Plosker, G.L.¹ Foster, R.H.²

7
- 18044404792
- Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation
- M. Salizzoni A. Cavallari A. Risalti Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation Transplant Proc 33 2001 2258 2262
- (2001) Transplant Proc , vol.33 , pp. 2258-2262
- Salizzoni, M.¹ Cavallari, A.² Risalti, A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.